Related Experiment Video

Updated: May 5, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K

Multiple sclerosis and infection: history, EBV, and the search for mechanism

Elliott D SoRelle1, Micah A Luftig1

  • 1Department of Molecular Genetics & Microbiology, Center for Virology, Duke University, Durham, North Carolina, USA.

Microbiology and Molecular Biology Reviews : MMBR
|January 16, 2025
PubMed

Insights

Epstein-Barr virus (EBV) is a compelling trigger for multiple sclerosis (MS). Further research is needed to understand EBV's role in MS neuroinflammation and demyelination for developing targeted therapies.

Area of Science:

  • Neuroimmunology
  • Virology
  • Pathology

Background:

  • Infection has been a long-standing hypothesis for the cause of multiple sclerosis (MS).
  • Recent evidence strongly implicates Epstein-Barr virus (EBV) as a trigger for MS.
  • The precise viral mechanisms linking EBV to MS neuroinflammation and demyelination remain unclear.

Purpose of the Study:

  • To investigate the mechanisms by which EBV potentiates the onset of MS.
  • To understand EBV's role in the chronic activity and progression of MS.
  • To inform the development of EBV-targeted therapies for MS management and prevention.

Main Methods:

  • Leveraging existing basic and clinical research on MS.
  • Developing and utilizing suitable experimental models and techniques.
  • Interdisciplinary collaboration among virologists, molecular biologists, immunologists, and clinicians.

Main Results:

  • Clear and compelling evidence links EBV to MS onset.
  • Uncertainty persists regarding the specific viral mechanisms involved.
  • Understanding these mechanisms is crucial for advancing MS research.

Conclusions:

  • Defining EBV's contribution to MS pathology requires further investigation.
  • Advanced experimental models and techniques are essential.
  • This research aims to broaden understanding of virus-driven neuroinflammation and guide EBV-targeted MS therapies.
Keywords:
EBVEpstein-Barr virusMSautoimmune diseasecentral nervous system infectionsetiologymultiple sclerosisviral infection

More Related Videos

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.1K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.0K

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
217
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
108
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
45
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
27
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
30
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31